10 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-accepts-biologics-license-application-for-sobis-nasp-for-patients-with-uncontrolled-gout-302552102.html
01 Dec 2021
// BIOSPACE
https://www.biospace.com/article/releases/sobi-and-selecta-biosciences-announce-completion-of-enrolment-in-dissolve-phase-3-study-evaluating-sel-212-for-chronic-refractory-gout/?s=71